WeDaita Launches AI Scientists to Accelerate Drug Discovery

WeDaita is proud to announce the launch of WeDaita AI Scientists, intelligent research agents designed to integrate seamlessly into modern drug discovery workflows. Built on next-generation AI with advanced reasoning and deep-agent capabilities, these AI Scientists help research teams accelerate discovery, generate novel hypotheses, and explore disease biology with unprecedented depth and efficiency.

WeDaita AI Scientists combine multimodal, disease-specific data, biomedical literature, and knowledge graphs into a unified intelligence layer—enabling rapid insight generation that traditionally requires weeks of manual analysis.

The first supported disease area is Type 1 Diabetes (T1D), with additional indications actively in development. Best of all, these agents are available 24/7 and free to “hire” for now, making them an accessible and powerful addition to any R&D team.

Paired with BioMedAI, WeDaita’s domain-focused biomedical intelligence engine, researchers can supercharge early-stage activities such as target identification and disease–target association studies. These foundational steps are crucial in determining whether a future therapeutic program succeeds—because without a strong biological target, even the best drug design and clinical development cannot deliver impact.

With the combined power of AI Scientists and BioMedAI, WeDaita is redefining how scientific teams explore biology, uncover mechanisms, and drive forward the next generation of therapeutics.

For more information, visit WeDaita.com.